Amniotic membrane becoming more viable alternative for potential eye healing
Major advances in the use of amniotic membrane are making it a more ideal procedure in the field of ophthalmology for certain eye diseases and injuries.
The story of grafting and bandage methods in eye surgery reconstruction was featured in the August issue of EyeWorld Magazine.
“Amniotic membrane is a popular choice among ophthalmologists for many different types of ocular reconstruction surgeries pertaining to the anterior segment of the eye,” said Jennifer Wehmeyer, Scientist II, Research & Development at BioBridge Global.
Amniotic membrane, or amnion, is the innermost layer of the placenta that forms around the fetus. The amnion is carefully removed from the rest of the placenta, cleaned and sterilized, and then preserved for transplant through freezing or dehydration.
The use of amnion and related birth tissues continue to extend to applications beyond eyes. A recent study in Stem Cells Translational Medicine shows how stem cells from amniotic fluid can become a potential treatment for spina bifida, a birth defect of the spinal cord that affects about 1,645 babies each year.
Both studies are a small segment of the many studies researching applications of amnion.
“As our understanding of the biological milieu of amniotic membrane evolves and as we learn how these factors contribute to tissue regeneration and influence clinical outcomes, the use of amniotic membrane and amniotic membrane derived products will continue to expand,” said Wehmeyer.
The material that appears on this blog is for informational purposes only. In many instances, we are sharing information first reported elsewhere. Posting here does not imply any endorsement of specific research. When available, links to the original research content are available within the blog post. We are not responsible if information we make available on this site is not accurate, complete or current.
More from our blog: